The Patent Finder

Terms ending in 2038

Acceleron Pharma Inc.

Every in-force patent on Acceleron Pharma Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,021,527Transforming Growth Factor Beta Receptor Type II Fusion Polypeptides
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 12,195,519Transforming Growth Factor-Beta (TGF-BETA) Receptor Type II Fusion Polypeptides
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,267,865Variant Actriib Proteins and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 12,240,887Variant Actriib Proteins and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 12,421,295Tgf-Beta Superfamily Type I and Type II Receptor Heteromultimers and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 12,673,998ALK7 Binding Proteins and Uses Thereof
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 12,194,076Methods and Compositions for Treating Myelofibrosis
In force
 · Medium confidence
Suragani, Rajasekhar Naga Venkata SaiIn forceMedium confidence
US 12,054,753Methods of Treatment of Muscular Dystrophy with ALK4:ACTRIIB Heteromultimers
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by Acceleron Pharma Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited